« FDA Approvals - BioElectronics Issues Letter to ShareholdersFREDERICK, Md., May 4, 2012 /PRNewswire/ | Main | FDA approves imaging drug Amyvid Estimates brain amyloid plaque content »

Website claims and GMP violations continue to dominate FDA warning


Website claims and GMP violations continue to dominate FDA warning letters
Maryland-based From Fatigued to Fantastic, LLC also received a warning letter for language used on the company s website http://www.endfatigue.com relating to products promoted for conditions that cause the products to be drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)].
 

©2006 FDA-News.com. All rights reserved.